se of bifocal scanning (Vivascope, trademark [TM]) versus tissue biopsy in diagnosis of skin cancers

Not Applicable

Recruiting

• Conditions: on-Melanoma skin Cancer; Non-Melanoma skin Cancer; Skin - Dermatological conditions; Cancer - Non melanoma skin cancer

• Registration Number: ACTRN12610000450011
• Lead Sponsor: Royal Adelaide Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-06-02
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

All patients referred to Plastic and Reconstructive Surgery Department of Royal Adelaide Hospital or The Queen Elizabeth Hospital for excision, excisional biopsy, or biopsy of non-melanoma skin lesion who are willing to participate in the study

Exclusion Criteria

Patients not willing to participate in the study,
patients not able to understand the study information,
patients under the age of 18

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Comparability of Confocal Reflectance Microscopy to Histopathology<br>This will be evaluated by use of sensitivity, specificity, and negative predictive value calculations. The aim of the calculations is to determine if there is comparability between histology and confocal diagnoses.[Immediate]

Secondary Outcome Measures

Name	Time	Method
Positive predictive value of Confocal Reflectance Microscopy in determining margins of spread of skin malignancies<br>Assessed through calculation of positive predictive value of confocal imaging, as compared to histology (gold standard).[Immediate]